Cisatracurium Besylate
NDC 31722-312, Cisatracurium Besylate, injection, from Camber Pharmaceuticals Inc..
- Product NDC
- 31722-312
- Status
- Listed
- Labeler
- Camber Pharmaceuticals Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212432
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/31722-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-312-10 | 31722031210 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-312-10) / 20 mL in 1 VIAL, SINGLE-DOSE (31722-312-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d8b5eb77-b393-4cd7-86c5-d2a9d131f96d
Use it
Look up 31722-312 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-312 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-312. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.